BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 28351959)

  • 1. The innate immune system in human systemic lupus erythematosus.
    Weidenbusch M; Kulkarni OP; Anders HJ
    Clin Sci (Lond); 2017 Apr; 131(8):625-634. PubMed ID: 28351959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
    Chyuan IT; Tzeng HT; Chen JY
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.
    Beccastrini E; D'Elios MM; Emmi G; Silvestri E; Squatrito D; Prisco D; Emmi L
    Int J Immunopathol Pharmacol; 2013; 26(3):585-96. PubMed ID: 24067455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids.
    Kontaki E; Boumpas DT
    J Autoimmun; 2010 Nov; 35(3):206-11. PubMed ID: 20638241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic lupus erythematosus: from pathophysiology to treatment].
    Contin-Bordes C; Lazaro E; Pellegrin JL; Viallard JF; Moreau JF; Blanco P
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H9-13. PubMed ID: 19995652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Toll for lupus.
    Anders HJ
    Lupus; 2005; 14(6):417-22. PubMed ID: 16038103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate recognition of microbial-derived signals in immunity and inflammation.
    Zhang Y; Liang C
    Sci China Life Sci; 2016 Dec; 59(12):1210-1217. PubMed ID: 27888386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I IFN system in the development and manifestations of SLE.
    Elkon KB; Wiedeman A
    Curr Opin Rheumatol; 2012 Sep; 24(5):499-505. PubMed ID: 22832823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the key events of systemic lupus erythematosus pathogenesis.
    Husakova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):327-42. PubMed ID: 27003314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
    Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
    Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
    Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis.
    Lorenz G; Anders HJ
    Semin Nephrol; 2015 Sep; 35(5):410-26. PubMed ID: 26573544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The innate immune system in SLE: type I interferons and dendritic cells.
    Rönnblom L; Pascual V
    Lupus; 2008 May; 17(5):394-9. PubMed ID: 18490415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease.
    Cao X
    Nat Rev Immunol; 2016 Jan; 16(1):35-50. PubMed ID: 26711677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.